INVA
Innoviva Inc

1,493
Loading...
Loading...
Innoviva, Inc. is engaged in the development, commercialization, and financial management of biopharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate, and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M. Whitesides in November 1996 and is headquartered in Burlingame, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
127

Frequently Asked Questions

What is Market Cap of Innoviva Inc?
What is the 52-week high for Innoviva Inc?
What is the 52-week low for Innoviva Inc?
What is Innoviva Inc stock price today?
What was Innoviva Inc stock price yesterday?
What is the PE ratio of Innoviva Inc?
What is the Price-to-Book ratio of Innoviva Inc?
What is the 50-day moving average of Innoviva Inc?
How many employess does Innoviva Inc has?

Latest INVA News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.